You know the CFO said IPCI is not yet selling any shares. he said They are waiting for a better PPS. Listen to the last call. They have the chançe to sell up to 16,8 mil dollar and will do it on the NEXT catalyst. So please stop misleading. And o some DD.
you realy think everyone telling to take some profit is a short.... hahahahaha. What would you do if you bought PLUG at 0.38? 140000 shares... Where did you buy? I'm not saying PLUG can't go to 10 or 15 dollar, but at this point it's not a no brainer anymore.
I alerted PLUG at 0.38 dollar... I was almost sure PLUG would go over 1 dollar before year end. Well it did. But now i see some new investors post things out of PLUGs reach... Enjoy the ride, but don't forget to take profit.
And what about glucophage? Over 40 months as well imo... And then rexista results to hit end 2013 or first Q 2014...
FDA takes 40 months for approval... Effexor May 2010 + 40 months is sept 2013... So any day now... Protonix oct 2010 + 40 months is feb 2014....
let your own feeling rule...
I think this could be a great 2014 stock... getting in soon. still doing some DD
The companies already have an agreement for the development and commercialization of 5, 10, 15 and 20 mg strengths of generic Focalin XR. According to the deal, Intellipharmaceutics is responsible for all development costs of generic Focalin XR, while Par Pharma is responsible for bioequivalence costs, API costs, scale-up/stability costs and marketing of the product. Par Pharma is also responsible for all litigation expenses.
Additionally, according to the expanded agreement, Par Pharma will make an upfront payment to Intellipharmaceutics and the latter is also entitled to receive a share of profits from the sales of the drug.
"The Company has a ten year profit-sharing agreement with Par for the sale of dexmethylphenidate hydrochloride XR capsules in the U.S., which commences with the commercial launch of the product by Par. Additional details of the license agreement remain confidential."